Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States
Annals of Pharmacotherapy · 2024
DOI: 10.1177/10600280231190701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2024. Verfasst von Eren Watkins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Organon, Jersey City, NJ, USA. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, Vaginitis, Sexually Transmitted Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Organon.
Abstract (Originalsprache)
Background
Bacterial vaginosis (BV) is a highly prevalent vaginal infection.
Objectives
Primary objectives of this study were to examine treatment patterns among female patients with Medicaid coverage who were diagnosed with incident BV, the frequency of BV-associated complications, and health care resource utilization (HCRU) and associated costs of incident BV and its recurrence. Secondary objectives were to identify predictors of total all-cause health care costs and number of treatment courses.
Methods
Female patients aged 12-49 years with an incident vaginitis diagnosis and ≥1 pharmacy claim for a BV medication were selected from the Merative MarketScan Medicaid database (2017-2020). Additional treatment courses were evaluated during a ≥12-month follow-up period, in which new cases of BV-associated complications and HCRU and the associated costs were also measured. Generalized linear models were used to identify baseline predictors of total all-cause health care costs and number of treatment courses.
Results
An incident vaginitis diagnosis and ≥1 BV medication claim were present in 114 313 patients (mean age: 28.4 years; 48.6% black). During the follow-up, 56.6% had 1 treatment course, 24.9% had 2, 10.2% had 3, and 8.3% had ≥4; 43.4% had BV recurrence. Oral metronidazole (88.5%) was the most frequently prescribed medication. Nearly 1 in 5 had a new occurrence of a BV-associated complication; most (76.6%) were sexually transmitted infections (STIs). Total all-cause and BV-related costs averaged $5794 and $300, respectively, per patient; both increased among those with more treatment courses. Older age, pregnancy, comorbidity, any STIs, postprocedural gynecological infection (PGI), and infertility were predictive of higher total all-cause health care costs, while race/ethnicity other than white was predictive of lower costs. Older age, black race, any STIs, pelvic inflammatory disease, and PGI were predictive of >1 treatment courses. Conclusion and Relevance The high recurrence of BV represents an unmet need in women’s health care and better treatments are necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Organon, Jersey City, NJ, USA.
- Actu-real, Alpharetta, GA, USA.
- Novosys Health, Green Brook, NJ, USA.
- Capital Women's Care Division 64, Laurel, MD, USA.
- Holy Cross Hospital, Silver Spring, MD, USA.
- Robert Wood Johnson Medical School, Rutgers, New Brunswick, NJ, USA.
ORCID-Profile: Melissa Lingohr-Smith
Förderung
- Organon
Zitieren
APA
Watkins, E., Chow, C. M., Lingohr-Smith, M., Lin, J., Yong, C., Tangirala, K., Collins, K., Li, J., Brooks, R., & Amico, J. (2024). Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280231190701
Vancouver
Watkins E, Chow CM, Lingohr-Smith M, Lin J, Yong C, Tangirala K, et al. Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States. Annals of Pharmacotherapy. 2024. doi:10.1177/10600280231190701
BibTeX
@article{Watkins2024,
author = {Watkins, Eren and Chow, Clifton M and Lingohr-Smith, Melissa and Lin, Jay and Yong, Candice and Tangirala, Krishna and Collins, Kevin and Li, James and Brooks, Roy and Amico, Jennifer},
title = {Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States},
journal = {Annals of Pharmacotherapy},
year = {2024},
doi = {10.1177/10600280231190701}
}
EUVIMED